Spermidine vs Fisetin: Autophagy vs Senolysis for Longevity

They target different aging mechanisms (autophagy vs senolysis). Neither is proven to extend human lifespan. Spermidine has stronger epidemiological support; fisetin has stronger preclinical senolytic data. They are complementary rather than competing.

Combining them has not been studied. They are mechanistically complementary (autophagy + senolysis) addressing two hallmarks of aging, but there's no safety or efficacy data on the combination. Consult a healthcare provider.

Spermidine has the Bruneck cohort (n=829, 20-year follow-up) linking dietary intake to reduced mortality, plus the SmartAge trial showing memory benefits. Fisetin's human evidence is primarily safety/tolerability (AFFIRM trial pending).

Autophagy recycles damaged components within cells (proteins, organelles). Senolysis eliminates entire senescent cells that refuse to die. Autophagy = internal cleanup; senolysis = removing damaged cells.

The Bruneck study associated highest dietary spermidine intake with a 5.7-year mortality benefit over 20 years. The SmartAge trial showed memory improvement in older adults. Cross-species lifespan extension (yeast, worms, flies, mice) is remarkably consistent.

The 2018 Mayo Clinic screening identified fisetin as the most potent senolytic among 10 flavonoids. In mice, fisetin extended lifespan even when started late in life. Human validation is ongoing (AFFIRM trial).

Spermidine: daily, ~1–3 mg/day from supplements or wheat germ. Fisetin: intermittent senolytic protocols, ~20 mg/kg for 2-day courses monthly. Dosing reflects different biological rationales (continuous autophagy vs pulse senolysis).

Spermidine is abundant in wheat germ (~243 mg/kg), aged cheese, mushrooms, soy. Fisetin is in strawberries (~160 μg/g), apples, persimmons — but dietary intake averages only 0.4 mg/day, too low for senolytic doses.

Both are generally well-tolerated. Spermidine is a natural dietary polyamine with a long safety history. Fisetin at 20 mg/kg for 2-day courses showed mild GI symptoms. Neither has serious adverse events documented.

Spermidine's epidemiological benefit appears across age ranges. Fisetin's senolytic rationale targets accumulated senescent cells, which increase with age — so older adults may benefit most. Both are being studied in older populations.

Spermidine supplements vary; dietary sources (wheat germ) are cheap. Fisetin supplements tend to be more expensive due to sourcing. Costs depend on form and brand.

No — they target different problems. Autophagy recycles intracellular damage; senolysis removes entire senescent cells that resist autophagy. Both processes decline with age, and addressing both may be complementary.

Spermidine: autophagy markers (LC3-II), memory tests. Fisetin: senescent cell burden markers (p16, p21), SASP factors. Neither has widely validated, clinically accessible biomarkers for individual monitoring.

Spermidine extends lifespan across yeast, worms, flies, and mice with remarkable cross-species consistency. Fisetin extended lifespan in mice even when started late in life. Both have strong animal data.

Both are active areas of aging research targeting distinct hallmarks. Combining autophagy induction and senolysis is theoretically attractive but untested in humans. They represent promising but still-investigational approaches.